Sean McCutcheon Stock Analyst Profile - Raymond James Research Coverage - Stocknear

Sean McCutcheon

Stock Analyst at Raymond James

(2.94)
# 3015
Out of 5,504 analysts
10
Total ratings
Success rate
Average return
Main Sectors:
Top Industries:

9 Stocks

Name Action PT Current % Upside Ratings Updated
RVMD Revolution Medicines
Assumes: Strong Buy
72
47.28 52.28% 1 Sep 12, 2025
VIR Vir Biotechnology
Initiates Coverage On: Outperform
12
5.67 111.64% 1 Jul 11, 2025
JANX Janux Therapeutics
Initiates Coverage On: Outperform
65
24.55 164.77% 1 Jul 11, 2025
CMPX Compass Therapeutics
Reinstates: Outperform
9
3.52 155.68% 1 Jul 1, 2025
BDTX Black Diamond Therap...
Reinstates: Outperform
11
3.87 184.24% 1 Jul 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
23
7.91 190.77% 1 Nov 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
58 40
11.87 236.98% 1 Jun 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
92 70
57.2 22.38% 2 May 23, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
86
31.82 170.27% 1 Mar 13, 2024